Understanding pluripotency - how embryonic stem cells keep their options open
Date
2008
Authors
Johnson, B.
Shindo, N.
Rathjen, P.
Rathjen, J.
Keough, R.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Molecular Human Reproduction, 2008; 14(9):513-520
Statement of Responsibility
B.V. Johnson, N. Shindo, P.D. Rathjen, J. Rathjen and R.A. Keough
Conference Name
Abstract
Embryonic stem (ES) cells have the capacity to proliferate indefinitely in culture while maintaining the ability to differentiate to form any of the cells of the body. This unique combination of functions suggests that these cells could provide a potentially unlimited source of differentiated cells for the treatment of disease and aging. Understanding the molecular processes that underpin these functions in ES cells will allow us to harness their potential and develop strategies that control their differentiation. Combination of controlled differentiation with ground-breaking technologies for the reversal of somatic cells to an ES cell-like state promise the generation of patient-derived pluripotent cell lines for the treatment of disease in the future.
School/Discipline
Dissertation Note
Provenance
Description
Copyright © The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.